Since its foundation more than 100 new treatment concepts complying with its business strategy have been generated by or proposed to Pantarhei Bioscience.

Patent applications

So far, 52 patent applications have been either filed or prepared for filing. 17 patents have been granted. Please visit Patents to learn more about the ongoing applications.

(Pre-) Clinical studies

The company has ongoing (pre-)clinical studies in: breast cancer, prostate cancer, auto-immune diseases, cardiovascular applications, contraception, ovarian cancer and sexual dysfunction. Please visit Projects to be updated on the clinical status of the portfolio.

Contracts

The following projects have been outlicensed:

• An infertility project (LH-COH) to Merck Serono.
• A contraceptive project (VITS) to Bayer Schering Pharma.
• A device for vaginal home sampling to diagnose sexually transmitted infections and cervical cancer (DEVICE) to a newly created company Pantarhei Devices.

For the latest information, please visit News.